Evidence map›Paper›PMID 31496051›Full record

Trial reportJournal of the International AIDS Society2019

HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study.

Marcel Yotebieng, Christian Mpody, Noro Lr Ravelomanana, Martine Tabala, Fathy Malongo, Bienvenu Kawende, Paul Ntangu, Frieda Behets, Emile Okitolonda, CQI-PMTCT study team

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03048669 (Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo), which is not on this map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03048669 nacompletednot on this map

Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo

TypeinterventionalSponsorAlbert Einstein College of MedicineRan2016 to 2022Enrolled5,053ConditionsHIV/AIDS, Antiretroviral Therapy, Pregnancy Outcomes, HIV-exposed InfantsArmsContinuous quality improvement
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Observational
  18. Article
  19. Revista Mocambicana de ciencias de saude · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marcel YotebiengDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.ORCID 0000-0003-2110-2631
Christian MpodyDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Noro Lr RavelomananaDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Martine TabalaSchool of Public Health, The University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Fathy MalongoSchool of Public Health, The University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Bienvenu KawendeSchool of Public Health, The University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Paul NtanguNational AIDS Control Program (PNLS), Provincial Coordination, Kinshasa, Democratic Republic of Congo.
Frieda BehetsDepartment of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Emile OkitolondaSchool of Public Health, The University of Kinshasa, Kinshasa, Democratic Republic of Congo.
CQI-PMTCT study team

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Long term outcomes of therapy in women initiated on lifelong ART because of pregnancy in DR CongoR01HD087993 · NICHD · OHIO STATE UNIVERSITY · PI BABAKAZO, PELAGIE DIAMBALULA, YOTEBIENG, MARCEL · 2016 to 2020
$3.1M
NIAID NIH HHS U01 AI096299NICHD NIH HHS R01 HD087993
6 · The paper itself

Abstract

introductionPublished data on viral suppression among pregnant and breastfeeding women in routine care settings are scarce. Here, we report provincial estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors.

methodsThis cross-sectional study was conducted as part of a baseline assessment for the CQI-PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous quality interventions (CQI) on long-term ART outcomes among pregnant and breastfeeding women (NCT03048669). From November 2016 to June 2018, in each of the 35 Kinshasa provincial health zones (HZ), study teams visited the three busiest maternal and child health clinics, enrolled all HIV-positive pregnant or breastfeeding women (≤1 year post-delivery) receiving ART, and performed viral load testing. Log binomial models with generalized estimating equations to account for clustering at the HZ level, were used to estimate prevalence ratios comparing participants with undetected (<40 copies/mL) or suppressed (<1000 copies/mL) viral load across levels of individual and site characteristics.

resultsOf the 1752 eligible women, 1623 had viral load results available, including 38% who had been on ART for <6 months and 74% were on tenofovir-lamivudine-efavirenz. Viral load was undetectable in 53% of women and suppressed in 62%. Among women who were on ART for ≥12 months, only 60% and 67% respectively, had undetectable or suppressed viral load. Viral load was undetectable in 53%, 48% and 58% of women testing during pregnancy, at delivery, and in postpartum respectively. In multivariable log binomial models, duration of ART >12 months, older age, being married, disclosure of HIV status, receiving care in an urban health zone or one supported by PEPFAR were all positively associated with viral suppression.

conclusionsThe observed high level of detectable viral load suggests that high ART coverage alone without substantial efforts to improve the quality of care for pregnant and breastfeeding women, will not be enough to achieve the goal of virtual elimination of vertical HIV transmission in high-burden and limited resources settings like DRC.

Indexed as

AdultBreast FeedingCross-Sectional StudiesDemocratic Republic of the CongoFemaleHIV-1HIV InfectionsHumansPregnancyPregnancy Complications, InfectiousPrevalenceViral LoadYoung AdultHIVoption B+pregnant womenquality of caretreat alluniversal coveragevertical transmissionviral load monitoringviral suppression

Identifiers

PMID31496051
PMCPMC6732557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.